INCB# [002]

Related by string. INCB# [001] . INCB# [003] * * advanced compound INCB# . topical INCB# . compound INCB# . inhibitor INCB# *

Related by context. Frequent words. (Click for all words.) 69 AP# [003] 68 IMGN# 68 ISIS # 67 RG# [001] 67 tivozanib 67 XL# [003] 67 MGCD# [001] 66 CYT# 66 Zerenex 66 FOLOTYN 66 Perifosine 66 Phase 2b trial 65 RDEA# 65 perifosine 65 Phase 2b 65 Telaprevir 65 myelofibrosis 64 pralatrexate 64 Phase IIa trial 64 Locteron 64 Phase 2a 64 Phase Ib 64 linaclotide 64 voreloxin 64 Phase IIa clinical 64 Phase 2b study 63 telbivudine 63 Phase 1b 63 FTY# 63 Marqibo 63 Phase 2b clinical 63 ZYBRESTAT 63 Phase IIb 63 Phase IIb trial 63 Phase 2a clinical 62 mipomersen 62 MDV# 62 tolerability profile 62 tamibarotene 62 LymphoStat B 62 pharmacodynamic 62 tolerability 62 satraplatin 62 ambrisentan 62 carfilzomib 61 PRX # 61 picoplatin 61 pivotal Phase III 61 Phase IIa 61 lubiprostone 61 Alpharadin 61 monotherapy 61 ADVEXIN 61 HspE7 61 Phase IIb clinical 61 Phase III pivotal 61 panitumumab 61 Albuferon 61 ADX# 61 APD# 61 IDX# 61 laquinimod 61 daclizumab 61 Kuvan 61 investigational compound 61 JANUVIA 61 maraviroc 61 AMR# 61 ofatumumab 60 Bronchitol 60 vilazodone 60 hematologic malignancies 60 ALKS 60 Campath 60 clofarabine 60 sunitinib 60 PLX# 60 cutaneous T cell 60 CRx 60 dosing regimens 60 humanized monoclonal antibody 60 Androxal 60 AZD# 60 pharmacokinetic profile 60 Phase III clinical 60 ARRY 60 LEVADEX 60 T DM1 60 ASA# 60 Phase III 60 fidaxomicin 60 asenapine 59 MGCD# [002] 59 SPP# [001] 59 alemtuzumab 59 Prochymal 59 ACTEMRA 59 Cimzia 59 SEROQUEL 59 dasatinib 59 hematological malignancies

Back to home page